Episteme Prognostics Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $5.64M

  • Investors
  • 1

Episteme Prognostics General Information

Description

Developer of a diagnostic platform designed for predicting chemotherapy response in cancer patients. The company's technology utilizes proprietary chromatin accessibility profiling and epigenetic biomarker identification to analyze gene regulatory elements, providing oncology clinics with diagnostic microarrays, prognostic scoring systems, and companion diagnostics, enabling medical professionals to identify effective treatment paths and avoid unnecessary interventions.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 30 River Road
  • Apartment 8 East
  • New York, NY 10044
  • United States
+1 (617)
Primary Industry
Decision/Risk Analysis
Vertical(s)
Corporate Office
  • 30 River Road
  • Apartment 8 East
  • New York, NY 10044
  • United States
+1 (617)

Episteme Prognostics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Episteme Prognostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Seed Round 04-Sep-2026 $5.64M Completed Startup
2. Accelerator/Incubator Completed Startup
1. Seed Round 13-Apr-2023 $4.11M $4.11M Completed Startup
To view Episteme Prognostics’s complete valuation and funding history, request access »

Episteme Prognostics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed-2
Seed-1
To view Episteme Prognostics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Episteme Prognostics Patents

Episteme Prognostics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026024826-A1 Combination methods for profiling genetic mutations and chromatin accessibility Pending 25-Jul-2024
AU-2024243779-A1 Arrays targeting differentially accessible chromatin regions using quantitative polymerase chain reaction Pending 05-Apr-2023
EP-4689189-A1 Arrays targeting differentially accessible chromatin regions using quantitative polymerase chain reaction Pending 05-Apr-2023
US-20240344143-A1 Arrays targeting differentially accessible chromatin regions using quantitative polymerase chain reaction Pending 05-Apr-2023
WO-2024211731-A1 Arrays targeting differentially accessible chromatin regions using quantitative polymerase chain reaction Inactive 05-Apr-2023 C12Q1/6886
To view Episteme Prognostics’s complete patent history, request access »

Episteme Prognostics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Episteme Prognostics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
DRIVEN Accelerator Hub Accelerator/Incubator
To view Episteme Prognostics’s complete investors history, request access »

Episteme Prognostics FAQs

  • When was Episteme Prognostics founded?

    Episteme Prognostics was founded in 2021.

  • Where is Episteme Prognostics headquartered?

    Episteme Prognostics is headquartered in New York, NY.

  • What is the size of Episteme Prognostics?

    Episteme Prognostics has 2 total employees.

  • What industry is Episteme Prognostics in?

    Episteme Prognostics’s primary industry is Decision/Risk Analysis.

  • Is Episteme Prognostics a private or public company?

    Episteme Prognostics is a Private company.

  • What is Episteme Prognostics’s current revenue?

    The current revenue for Episteme Prognostics is .

  • How much funding has Episteme Prognostics raised over time?

    Episteme Prognostics has raised $9.8M.

  • Who are Episteme Prognostics’s investors?

    DRIVEN Accelerator Hub has invested in Episteme Prognostics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process